Platinum resistance. Experimental and clinical status.
It has become clear that multiple mechanisms of cellular resistance to platinum compounds exist; however, the knowledge that platinum resistance can not only be explained by processes such as reduced drug accumulation, and increased detoxification, has shifted the attention of researchers to more molecular mechanisms. The introduction of new techniques, such as the PCR technique for example, has opened the possibility to monitor genes involved in antitumor responses and may provide molecular information on the emergency of resistance.
University of California, UCSD Cancer Center, La Jolla.
G
G
Los
F M
FM
Muggia
D001692:Biological Transport / Q000502:physiology; D002986:Clinical Trials as Topic; D004260:DNA Repair; D004351:Drug Resistance / Q000502:physiology; D006801:Humans; D008658:Inactivation, Metabolic / Q000502:physiology; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism; D010984:Platinum / Q000493:pharmacokinetics / Q000494:pharmacology*; D015398:Signal Transduction / Q000502:physiology
D010984:Platinum